Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

NCT03596931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2018-09-12

No results posted yet for this study

Summary

This study aims to evaluate the effect of statin for primary prevention, towards lowering the incidence of heart failure, acute lung edema, malignant arrhythmia and death in ACS patients.

Conditions

  • Acute Coronary Syndrome
  • Acute Pulmonary Edema
  • Arrhythmias, Cardiac
  • Heart Failure

Interventions

DRUG

Statins (Cardiovascular Agents)

Prescribed with statins

Sponsors & Collaborators

  • Cengkareng General Hospital

    collaborator OTHER
  • Tarumanagara University

    lead OTHER

Principal Investigators

  • Andria Priyana, MD, FIHA · Department of Cardiology, Faculty of Medicine, Tarumanagara University

  • Angela F Sunjaya · Tarumanagara University

  • Anthony P Sunjaya · Tarumanagara University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-06-30
Completion
2018-08-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03596931 on ClinicalTrials.gov